Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-19T17:06:02.791Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of interdisciplinary approaches to deprescribing psychotropics on clinical outcomes in older residents of long-term care facilities

Published online by Cambridge University Press:  03 June 2021

Stephanie L. Harrison  and
Janet K. Sluggett
Stephanie L. Harrison*
Affiliation:
Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom
Janet K. Sluggett
Affiliation:
University of South Australia, UniSA Allied Health and Human Performance, Adelaide, South Australia, Australia Registry of Senior Australians (ROSA), Health Ageing Research Consortium, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
*
Email: [email protected]
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 33 , Special Issue 6: Issue Theme: Diverse Strategies for Improving Seniors’ Well-Being , June 2021 , pp. 543 - 546
Copyright
© International Psychogeriatric Association 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aerts, L. et al. (2019). Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: Insights from the HALT study. International Journal of Geriatric Psychiatry, 34, 1572–1581.CrossRefGoogle Scholar
Australian Government Aged Care Quality and Safety Commission (2020). Better use of medication in aged care project. Commonwealth of Australia. Available at: https://www.agedcarequality.gov.au/providers/better-use-medication-aged-care-project.Google Scholar
Briesacher, B.A., Tjia, J., Field, T., Peterson, D. and Gurwitz, J.H. (2013). Antipsychotic use among nursing home residents. JAMA, 309, 440–442.CrossRefGoogle ScholarPubMed
Brodaty, H. et al. (2018). Antipsychotic deprescription for older adults in long-term care: The HALT Study. Journal of the American Medical Directors Association, 19, 592–600.e597.CrossRefGoogle ScholarPubMed
Commonwealth Department of Health and Ageing (2020). The National Strategy for Quality Use of Medicines. Canberra: Commonwealth of Australia.Google Scholar
Dyer, S.M., Harrison, S.L., Laver, K., Whitehead, C. and Crotty, M. (2018). An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. International Psychogeriatrics, 30, 295–309.CrossRefGoogle ScholarPubMed
Harrison, S.L. et al. (2020). The dispensing of psychotropic medicines to older people before and after they enter residential aged care. Medical Journal of Australia, 212, 309–313.CrossRefGoogle ScholarPubMed
Hoyle, D.J., Bindoff, I.K., Clinnick, L.M., Peterson, G.M. and Westbury, J.L. (2018). Clinical and economic outcomes of interventions to reduce antipsychotic and benzodiazepine use within nursing homes: a systematic review. Drugs & Aging, 35, 123–134.CrossRefGoogle ScholarPubMed
Hoyle, D.J., Peterson, G.M., Bindoff, I.K., Clinnick, L.M., Bindoff, A.D. and Breen, J.L. (2020). Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care. International Psychogeriatrics. doi: 10.1017/S1041610220000940 CrossRefGoogle Scholar
Hughes, G.A. et al. (2019). Would you like to participate? Factors impacting on participant recruitment for quality use of medicines interventions in residential aged care. Research in Social and Administrative Pharmacy, 15, e12.CrossRefGoogle Scholar
Kalogianis, M.J. et al. (2016). Are residents of aged care facilities willing to have their medications deprescribed? Research in Social and Administrative Pharmacy, 12, 784–788.CrossRefGoogle Scholar
Maust, D.T. et al. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry, 72, 438–445.CrossRefGoogle ScholarPubMed
Moniz Cook, E.D., Swift, K., James, I., Malouf, R., De Vugt, M. and Verhey, F. (2012). Functional analysis-based interventions for challenging behaviour in dementia. Cochrane Database of Systematic Reviews, Cd006929.Google Scholar
Ray, W.A., Federspiel, C.F. and Schaffner, W. (1980). A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health, 70, 485–491.CrossRefGoogle ScholarPubMed
Royal Commission into Aged Care Quality and Safety (2019). Interim report: Neglect. Volume 1.: Commonwealth of Australia.Google Scholar
Schneider, L.S., Dagerman, K. and Insel, P.S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. The American Journal of Geriatric Psychiatry, 14, 191–210.CrossRefGoogle ScholarPubMed
Szczepura, A., et al. (2016). Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4-year period. BMJ Open, 6, e009882.CrossRefGoogle ScholarPubMed
Tsoi, K.K.F., Chan, J.Y.C., Ng, Y.M., Lee, M.M.Y., Kwok, T.C.Y. and Wong, S.Y.S. (2018). Receptive music therapy is more effective than interactive music therapy to relieve behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Journal of the American Medical Directors Association, 19, 568–576.e563.CrossRefGoogle ScholarPubMed
Westaway, K., Sluggett, J., Alderman, C., Moffat, A., Procter, N. and Roughead, E. (2020). The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: a literature review. Dementia, 19, 1189–1202.CrossRefGoogle Scholar
Westbury, J.L. et al. (2018). RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Medical Journal of Australia, 208, 398–403.CrossRefGoogle ScholarPubMed